Breaking News

Financial Report: Sigma-Aldrich

February 7, 2013

Revenues up 7% in the quarter

4Q Revenues: $655 million (+7%)

4Q Earnings: $116 million (+7%)

FY Revenues: $2.6 billion (+5%)

FY Earnings: $460 million (+1%)

Comments: Growth in the quarter was driven by a 3% increase in Research and Sigma-Aldrich Fine Chemicals (SAFC) with sales growth of 2% and 5%, respectively. Acquisitions contributed 6% to sales growth.

Related Contract Manufacturing:

blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies